BioLineRx (BLRX) Return on Assets (2013 - 2025)

BioLineRx's Return on Assets history runs 13 years deep, the most recent figure standing at 0.0% for Q4 2025.

• In Q4 2025, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Assets was 0.0% for Q4 2025 at BioLineRx, down from 0.0% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q3 2025 to a low of 0.01% in Q4 2023.
• Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2022.
• The sharpest annual moves came in 2021 and 2024: Return on Assets changed 0 bps in 2021, then gained 1 bps in 2024.
• A 5-year view of Return on Assets shows it stood at 0.0% in 2021, then dropped by 22 bps to 0.0% in 2022, then slumped by 128 bps to 0.01% in 2023, then surged by 77 bps to 0.0% in 2024, then rose by 5 bps to 0.0% in 2025.
• The last three Return on Assets figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.